雜志介紹

Cancer And Metastasis Reviews雜志介紹

《Cancer And Metastasis Reviews》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱癌癥和轉(zhuǎn)移評(píng)論，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為7.7，最新CiteScore 指數(shù)為17。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment

  Author: Liu, Qiu-Luo; Zhou, Huijie; Zhou, Zong-Guang; Chen, Hai-Ning

• Circadian disruption: from mouse models to molecular mechanisms and cancer therapeutic targets

  Author: Wang, Yu; Guo, Haidong; He, Feng

• Potential biomarkers for immunotherapy in non-small-cell lung cancer

  Author: Wang, Xing; Qiao, Ziyun; Aramini, Beatrice; Lin, Dong; Li, Xiaolong; Fan, Jiang

• Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers

  Author: Wang, Yu; Deng, Baocheng

英文介紹

Cancer And Metastasis Reviews雜志英文介紹

Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments.

Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.

A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative.